Centrexion Therapeutics Corp announced that it will receive $12,859,762 in funding on December 28, 2023. The company will issue convertible corporate debt and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |